Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1999 Aug;65(2):279–286. doi: 10.1086/302519

The bare lymphocyte syndrome: molecular clues to the transcriptional regulation of major histocompatibility complex class II genes.

A DeSandro 1, U M Nagarajan 1, J M Boss 1
PMCID: PMC1377925  PMID: 10417269

Full Text

The Full Text of this article is available as a PDF (347.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bontron S., Steimle V., Ucla C., Eibl M. M., Mach B. Two novel mutations in the MHC class II transactivator CIITA in a second patient from MHC class II deficiency complementation group A. Hum Genet. 1997 Apr;99(4):541–546. doi: 10.1007/s004390050403. [DOI] [PubMed] [Google Scholar]
  2. Boss J. M. Regulation of transcription of MHC class II genes. Curr Opin Immunol. 1997 Feb;9(1):107–113. doi: 10.1016/s0952-7915(97)80166-5. [DOI] [PubMed] [Google Scholar]
  3. Brown J. A., He X. F., Westerheide S. D., Boss J. M. Characterization of the expressed CIITA allele in the class II MHC transcriptional mutant RJ2.2.5. Immunogenetics. 1996;43(1-2):88–91. doi: 10.1007/BF00186611. [DOI] [PubMed] [Google Scholar]
  4. Bénichou B., Strominger J. L. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4285–4288. doi: 10.1073/pnas.88.10.4285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chang C. H., Fodor W. L., Flavell R. A. Reactivation of a major histocompatibility complex class II gene in mouse plasmacytoma cells and mouse T cells. J Exp Med. 1992 Nov 1;176(5):1465–1469. doi: 10.1084/jem.176.5.1465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chang C. H., Guerder S., Hong S. C., van Ewijk W., Flavell R. A. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity. 1996 Feb;4(2):167–178. doi: 10.1016/s1074-7613(00)80681-0. [DOI] [PubMed] [Google Scholar]
  7. Clausen B. E., Waldburger J. M., Schwenk F., Barras E., Mach B., Rajewsky K., Förster I., Reith W. Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice. Immunity. 1998 Feb;8(2):143–155. doi: 10.1016/s1074-7613(00)80467-7. [DOI] [PubMed] [Google Scholar]
  8. Cressman D. E., Chin K. C., Taxman D. J., Ting J. P. A defect in the nuclear translocation of CIITA causes a form of type II bare lymphocyte syndrome. Immunity. 1999 Feb;10(2):163–171. doi: 10.1016/s1074-7613(00)80017-5. [DOI] [PubMed] [Google Scholar]
  9. Denzin L. K., Cresswell P. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell. 1995 Jul 14;82(1):155–165. doi: 10.1016/0092-8674(95)90061-6. [DOI] [PubMed] [Google Scholar]
  10. Durand B., Sperisen P., Emery P., Barras E., Zufferey M., Mach B., Reith W. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J. 1997 Mar 3;16(5):1045–1055. doi: 10.1093/emboj/16.5.1045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Elhasid R., Etzioni A. Major histocompatibility complex class II deficiency: a clinical review. Blood Rev. 1996 Dec;10(4):242–248. doi: 10.1016/s0268-960x(96)90008-9. [DOI] [PubMed] [Google Scholar]
  12. Fondaneche M. C., Villard J., Wiszniewski W., Jouanguy E., Etzioni A., Le Deist F., Peijnenburg A., Casanova J. L., Reith W., Mach B. Genetic and molecular definition of complementation group D in MHC class II deficiency. Hum Mol Genet. 1998 May;7(5):879–885. doi: 10.1093/hmg/7.5.879. [DOI] [PubMed] [Google Scholar]
  13. Fontes J. D., Kanazawa S., Jean D., Peterlin B. M. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes. Mol Cell Biol. 1999 Jan;19(1):941–947. doi: 10.1128/mcb.19.1.941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gladstone, Pious D. Stable variants affecting B cell alloantigens in human lymphoid cells. Nature. 1978 Feb 2;271(5644):459–461. doi: 10.1038/271459a0. [DOI] [PubMed] [Google Scholar]
  15. Gobin S. J., Peijnenburg A., Keijsers V., van den Elsen P. J. Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity. 1997 May;6(5):601–611. doi: 10.1016/s1074-7613(00)80348-9. [DOI] [PubMed] [Google Scholar]
  16. Gobin S. J., Peijnenburg A., van Eggermond M., van Zutphen M., van den Berg R., van den Elsen P. J. The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes. Immunity. 1998 Oct;9(4):531–541. doi: 10.1016/s1074-7613(00)80636-6. [DOI] [PubMed] [Google Scholar]
  17. Griscelli C., Lisowska-Grospierre B., Mach B. Combined immunodeficiency with defective expression in MHC class II genes. Immunodefic Rev. 1989;1(2):135–153. [PubMed] [Google Scholar]
  18. Kara C. J., Glimcher L. H. In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome. Science. 1991 May 3;252(5006):709–712. doi: 10.1126/science.1902592. [DOI] [PubMed] [Google Scholar]
  19. Klein C., Lisowska-Grospierre B., LeDeist F., Fischer A., Griscelli C. Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J Pediatr. 1993 Dec;123(6):921–928. doi: 10.1016/s0022-3476(05)80388-9. [DOI] [PubMed] [Google Scholar]
  20. Kretsovali A., Agalioti T., Spilianakis C., Tzortzakaki E., Merika M., Papamatheakis J. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator. Mol Cell Biol. 1998 Nov;18(11):6777–6783. doi: 10.1128/mcb.18.11.6777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Martin B. K., Chin K. C., Olsen J. C., Skinner C. A., Dey A., Ozato K., Ting J. P. Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity. 1997 May;6(5):591–600. doi: 10.1016/s1074-7613(00)80347-7. [DOI] [PubMed] [Google Scholar]
  22. Masternak K., Barras E., Zufferey M., Conrad B., Corthals G., Aebersold R., Sanchez J. C., Hochstrasser D. F., Mach B., Reith W. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat Genet. 1998 Nov;20(3):273–277. doi: 10.1038/3081. [DOI] [PubMed] [Google Scholar]
  23. Moreno C. S., Beresford G. W., Louis-Plence P., Morris A. C., Boss J. M. CREB regulates MHC class II expression in a CIITA-dependent manner. Immunity. 1999 Feb;10(2):143–151. doi: 10.1016/s1074-7613(00)80015-1. [DOI] [PubMed] [Google Scholar]
  24. Moreno C. S., Rogers E. M., Brown J. A., Boss J. M. Regulatory factor X, a bare lymphocyte syndrome transcription factor, is a multimeric phosphoprotein complex. J Immunol. 1997 Jun 15;158(12):5841–5848. [PubMed] [Google Scholar]
  25. Nagarajan U. M., Louis-Plence P., DeSandro A., Nilsen R., Bushey A., Boss J. M. RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity. 1999 Feb;10(2):153–162. doi: 10.1016/s1074-7613(00)80016-3. [DOI] [PubMed] [Google Scholar]
  26. Peijnenburg A., Van Eggermond M. C., Van den Berg R., Sanal O., Vossen J. M., Van den Elsen P. J. Molecular analysis of an MHC class II deficiency patient reveals a novel mutation in the RFX5 gene. Immunogenetics. 1999 Apr;49(4):338–345. doi: 10.1007/s002510050501. [DOI] [PubMed] [Google Scholar]
  27. Peters P. J., Neefjes J. J., Oorschot V., Ploegh H. L., Geuze H. J. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature. 1991 Feb 21;349(6311):669–676. doi: 10.1038/349669a0. [DOI] [PubMed] [Google Scholar]
  28. Riley J. L., Westerheide S. D., Price J. A., Brown J. A., Boss J. M. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity. 1995 May;2(5):533–543. doi: 10.1016/1074-7613(95)90033-0. [DOI] [PubMed] [Google Scholar]
  29. Seidl C., Saraiya C., Osterweil Z., Fu Y. P., Lee J. S. Genetic complexity of regulatory mutants defective for HLA class II gene expression. J Immunol. 1992 Mar 1;148(5):1576–1584. [PubMed] [Google Scholar]
  30. Steimle V., Durand B., Barras E., Zufferey M., Hadam M. R., Mach B., Reith W. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 1995 May 1;9(9):1021–1032. doi: 10.1101/gad.9.9.1021. [DOI] [PubMed] [Google Scholar]
  31. Steimle V., Otten L. A., Zufferey M., Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell. 1993 Oct 8;75(1):135–146. [PubMed] [Google Scholar]
  32. Steimle V., Siegrist C. A., Mottet A., Lisowska-Grospierre B., Mach B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science. 1994 Jul 1;265(5168):106–109. doi: 10.1126/science.8016643. [DOI] [PubMed] [Google Scholar]
  33. Villard J., Lisowska-Grospierre B., van den Elsen P., Fischer A., Reith W., Mach B. Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency. N Engl J Med. 1997 Sep 11;337(11):748–753. doi: 10.1056/NEJM199709113371104. [DOI] [PubMed] [Google Scholar]
  34. Villard J., Reith W., Barras E., Gos A., Morris M. A., Antonarakis S. E., Van den Elsen P. J., Mach B. Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiency. Hum Mutat. 1997;10(6):430–435. doi: 10.1002/(SICI)1098-1004(1997)10:6<430::AID-HUMU3>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
  35. Westerheide S. D., Boss J. M. Orientation and positional mapping of the subunits of the multicomponent transcription factors RFX and X2BP to the major histocompatibility complex class II transcriptional enhancer. Nucleic Acids Res. 1999 Apr 1;27(7):1635–1641. doi: 10.1093/nar/27.7.1635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Williams G. S., Malin M., Vremec D., Chang C. H., Boyd R., Benoist C., Mathis D. Mice lacking the transcription factor CIITA--a second look. Int Immunol. 1998 Dec;10(12):1957–1967. doi: 10.1093/intimm/10.12.1957. [DOI] [PubMed] [Google Scholar]
  37. Wright K. L., Chin K. C., Linhoff M., Skinner C., Brown J. A., Boss J. M., Stark G. R., Ting J. P. CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo. Proc Natl Acad Sci U S A. 1998 May 26;95(11):6267–6272. doi: 10.1073/pnas.95.11.6267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Zhou H., Glimcher L. H. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity. 1995 May;2(5):545–553. doi: 10.1016/1074-7613(95)90034-9. [DOI] [PubMed] [Google Scholar]
  39. de Préval C., Lisowska-Grospierre B., Loche M., Griscelli C., Mach B. A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. Nature. 1985 Nov 21;318(6043):291–293. doi: 10.1038/318291a0. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES